Replimune is a Massachusetts-based biotechnology company that develops cancer therapies. Its filings show it spent about $120,000 across three disclosures, all on health-related lobbying about advanced melanoma treatments. The company used Farragut Partners LLP to engage with lawmakers on issues tied to those therapies.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CONSTANTINE HINGSON
The latest disclosures for this client.
FARRAGUT PARTNERS LLP
1TFARRAGUT PARTNERS LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FARRAGUT PARTNERS LLP
EDWARD WHITFIELD
FARRAGUT PARTNERS LLP
JEFF MACKINNON
FARRAGUT PARTNERS LLP
JEFFERY C. MORTIER
FARRAGUT PARTNERS LLP
JODY SHINTARO GALE
FARRAGUT PARTNERS LLP
KRISTEN BAUTZ
FARRAGUT PARTNERS LLP
mr DYLAN MOORE
FARRAGUT PARTNERS LLP
SARAH WALTER
FARRAGUT PARTNERS LLP
FARRAGUT PARTNERS LLP
Q4FARRAGUT PARTNERS LLP
Q3FARRAGUT PARTNERS LLP
RR